PTC Therapeutics OverviewPTC Therapeutics EBIT
EBIT (Earnings Before Interest and Taxes) analysis for PTCT.
Quarterly EBIT
$44.96M
↓ 95.33% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$71.96M
↓ 108.83% YoY
Trailing 12 months ending Mar 31, 2026
PTC Therapeutics OverviewEBIT (Earnings Before Interest and Taxes) analysis for PTCT.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026